記事の要約: がん治療における免疫チェックポイント阻害薬（ICI）は、多くの患者の生存期間を延ばす効果がありますが、抗腫瘍免疫応答が抑制されている患者には限界があります。最近、個別化mRNAがんワクチンが開発され、ICIへの感受性を高める可能性が示されていますが、製造コストや時間が課題です。新たに、非腫瘍関連抗原をコードするmRNAワクチンが抗腫瘍免疫を誘導することが報告されました。ESMO2025では、コロナワクチン接種がICI治療の生存期間（OS）を有意に延長する可能性についても言及されています。
「2025 esmo esmo 2025」に関する記事です: https://www.carenet.com/news/general/carenet/61686
がん治療のICI、コロナワクチン接種でOS改善か／ESMO2025｜CareNet.com
免疫チェックポイント阻害薬（ICI）は、多くのがん患者の生存期間を延長するが、抗腫瘍免疫応答が抑制されている患者への効果は限定的である。現在、個別化mRNAがんワクチンが開発されており、ICIへの感受性を高めることが知られているが、製造のコストや時間の課題がある。そのようななか、非腫瘍関連抗原をコードするmRNAワクチンも抗腫瘍免疫を誘導するという発見が報告されている。そこで、Adam J. Grippin氏（米国・テキサ…
www.carenet.com
October 31, 2025 at 12:56 PM
Everybody can reply
From #ESMO2025 - Prof. Jeanne Tie explains why ctDNA-guided treatment de-escalation could be considered in certain patients with #ColonCancer despite the trial not meeting its primary endpoint.
Watch the full interview 👉 buff.ly/EZ6gTh6
#OncSky #MedNews
Watch the full interview 👉 buff.ly/EZ6gTh6
#OncSky #MedNews
October 31, 2025 at 9:02 AM
Everybody can reply
Unser November-Programm für die interdisziplinären Fortbildungen:
Alle mittwochs, 16.15 Uhr, ohne Anmeldung
nct-heidelberg.de/veranstaltun...
Ausnahme: ESMO-Highlights, 12.11.25, indico.dkfz.de/e/ESMO2025
Alle mittwochs, 16.15 Uhr, ohne Anmeldung
nct-heidelberg.de/veranstaltun...
Ausnahme: ESMO-Highlights, 12.11.25, indico.dkfz.de/e/ESMO2025
October 30, 2025 at 4:54 PM
Everybody can reply
1 likes
Cancer du poumon : des nouveautés qui révolutionnent les traitements
Tour d’horizon des études qui ont marqué l’#ESMO2025 en oncologie thoracique : ivonescimab, sac TMT, tarlatamab et plus… Avec Marie Wislez et Nicolas Girard
ms.spr.ly/63323tDUEd
Tour d’horizon des études qui ont marqué l’#ESMO2025 en oncologie thoracique : ivonescimab, sac TMT, tarlatamab et plus… Avec Marie Wislez et Nicolas Girard
ms.spr.ly/63323tDUEd
Cancer du poumon : des nouveautés qui révolutionnent les traitements
Tour d’horizon des études qui ont marqué l’ESMO 2025 en oncologie thoracique : ivonescimab, sac TMT, tarlatamab et plus… Avec Marie Wislez et Nicolas Girard
ms.spr.ly
October 30, 2025 at 2:02 PM
Everybody can reply
1 likes
From 17–21 Oct, the global oncology community gathered in Berlin at #ESMO2025. As the official accommodation partner, K.I.T. Group proudly supported 37,000+ participants — ensuring a seamless experience.
Teamwork, flexibility & great partners, that’s how event magic happens!
Teamwork, flexibility & great partners, that’s how event magic happens!
October 30, 2025 at 8:08 AM
Everybody can reply
The TROP2 ADC sac-TMT improved survival, compared with platinum-based chemotherapy, in patients with EGFR-mutated NSCLC who had progressed on EGFR-targeted TKIs. Presented at #ESMO25.
https://bit.ly/3LeE8Bl
#lcsm #ESMO2025
https://bit.ly/3LeE8Bl
#lcsm #ESMO2025
Novel ADC Outperforms Chemotherapy in EGFR-Mutated NSCLC Survival
OptiTROP-Lung04 study showed sac-TMT improved survival in pts with EGFR-mutated NSCLC who had progressed on EGFR-targeted TKIs, compared with chemotherapy.
bit.ly
October 29, 2025 at 5:10 PM
Everybody can reply
It’s so hard keeping Christopher Jackson & @drkiwikate.bsky.social on track from over here in far west New Zealand but as usual, we somehow manage to mix the latest info with a few laughs, covering ESMO Berlin. Enjoy and look out for part 2, out soon.
#medsky #oncsky #onced #ojc #oncology #esmo2025
#medsky #oncsky #onced #ojc #oncology #esmo2025
October 29, 2025 at 12:32 PM
Everybody can reply
🚨 Registration is open! Join global experts for the #ESMO25 Congress Highlights Webinar on Breast & Gynaecological Cancers.
🔗 Register now with your ESMO account: https://ow.ly/9lZi50XiUpN
#Oncology #BreastCancer #GynaeCancer #ESMO2025
🔗 Register now with your ESMO account: https://ow.ly/9lZi50XiUpN
#Oncology #BreastCancer #GynaeCancer #ESMO2025
October 29, 2025 at 10:55 AM
Everybody can reply
2 likes
NEW PODCAST: Grab your coffee and your bingo card (yes, it's downloadable so you can play along!)☕🎲
It’s ESMO Oncology Journal Club time! Part 1 t.ly/hk8pe
@craigunderhill.bsky.social, @drkiwikate.bsky.social & Christopher Jackson break down the abstracts from #ESMO2025
#OJC #MedEd #OncologyPodcast
It’s ESMO Oncology Journal Club time! Part 1 t.ly/hk8pe
@craigunderhill.bsky.social, @drkiwikate.bsky.social & Christopher Jackson break down the abstracts from #ESMO2025
#OJC #MedEd #OncologyPodcast
October 28, 2025 at 11:01 PM
Everybody can reply
1 quotes
2 likes
Adjuvant T-DXd can improve outcomes when compared to T-DM1 in patients with high-risk, HER2-positive early #breastcancer who have residual invasive disease. Presented at #ESMO2025.
https://bit.ly/4hAhkIk
#bcsm #BCAM #BreastCancerAwarenessMonth
https://bit.ly/4hAhkIk
#bcsm #BCAM #BreastCancerAwarenessMonth
T-DXd Bests T-DM1 in HER2+ Early Breast Cancer
Adjuvant T-DXd can improve outcomes vs T-DM1 in patients with high-risk, HER2+ early breast cancer and residual invasive disease, data suggest.
bit.ly
October 28, 2025 at 6:32 PM
Everybody can reply
MSI-H大腸がん、ニボルマブへのイピリムマブ追加でPFS延長傾向（CheckMate 8HW）／ESMO2025｜CareNet.com - CareNet.com
news.google.com/rss/articles/CBMiX0FVX3lxTFBpRzIyd1RwR3VoQ09MOFVhaVZDeHVtNVpnTUhpd18xMFJmTjRqVktxR2RiU3BMZmxERHJwS3NKSGltMURFeDFyQXlnc01ONW1GcGhNRXg5RlZKUl9ORE1B?oc=5
news.google.com/rss/articles/CBMiX0FVX3lxTFBpRzIyd1RwR3VoQ09MOFVhaVZDeHVtNVpnTUhpd18xMFJmTjRqVktxR2RiU3BMZmxERHJwS3NKSGltMURFeDFyQXlnc01ONW1GcGhNRXg5RlZKUl9ORE1B?oc=5
October 28, 2025 at 5:09 AM
Everybody can reply
MSI-H大腸がん、ニボルマブへのイピリムマブ追加でPFS延長傾向（CheckMate 8HW）／ESMO2025｜CareNet.com - CareNet.com
news.google.com/rss/articles/CBMiX0FVX3lxTFBpRzIyd1RwR3VoQ09MOFVhaVZDeHVtNVpnTUhpd18xMFJmTjRqVktxR2RiU3BMZmxERHJwS3NKSGltMURFeDFyQXlnc01ONW1GcGhNRXg5RlZKUl9ORE1B?oc=5
news.google.com/rss/articles/CBMiX0FVX3lxTFBpRzIyd1RwR3VoQ09MOFVhaVZDeHVtNVpnTUhpd18xMFJmTjRqVktxR2RiU3BMZmxERHJwS3NKSGltMURFeDFyQXlnc01ONW1GcGhNRXg5RlZKUl9ORE1B?oc=5
October 28, 2025 at 4:09 AM
Everybody can reply
MSI-H大腸がん、ニボルマブへのイピリムマブ追加でPFS延長傾向（CheckMate 8HW）／ESMO2025｜CareNet.com - CareNet.com
news.google.com/rss/articles/CBMiX0FVX3lxTFBpRzIyd1RwR3VoQ09MOFVhaVZDeHVtNVpnTUhpd18xMFJmTjRqVktxR2RiU3BMZmxERHJwS3NKSGltMURFeDFyQXlnc01ONW1GcGhNRXg5RlZKUl9ORE1B?oc=5
news.google.com/rss/articles/CBMiX0FVX3lxTFBpRzIyd1RwR3VoQ09MOFVhaVZDeHVtNVpnTUhpd18xMFJmTjRqVktxR2RiU3BMZmxERHJwS3NKSGltMURFeDFyQXlnc01ONW1GcGhNRXg5RlZKUl9ORE1B?oc=5
October 28, 2025 at 3:09 AM
Everybody can reply
MSI-H大腸がん、ニボルマブへのイピリムマブ追加でPFS延長傾向（CheckMate 8HW）／ESMO2025｜CareNet.com - CareNet.com
news.google.com/rss/articles/CBMiX0FVX3lxTFBpRzIyd1RwR3VoQ09MOFVhaVZDeHVtNVpnTUhpd18xMFJmTjRqVktxR2RiU3BMZmxERHJwS3NKSGltMURFeDFyQXlnc01ONW1GcGhNRXg5RlZKUl9ORE1B?oc=5
news.google.com/rss/articles/CBMiX0FVX3lxTFBpRzIyd1RwR3VoQ09MOFVhaVZDeHVtNVpnTUhpd18xMFJmTjRqVktxR2RiU3BMZmxERHJwS3NKSGltMURFeDFyQXlnc01ONW1GcGhNRXg5RlZKUl9ORE1B?oc=5
October 28, 2025 at 2:09 AM
Everybody can reply
MSI-H大腸がん、ニボルマブへのイピリムマブ追加でPFS延長傾向（CheckMate 8HW）／ESMO2025｜CareNet.com - CareNet.com
news.google.com/rss/articles/CBMiX0FVX3lxTFBpRzIyd1RwR3VoQ09MOFVhaVZDeHVtNVpnTUhpd18xMFJmTjRqVktxR2RiU3BMZmxERHJwS3NKSGltMURFeDFyQXlnc01ONW1GcGhNRXg5RlZKUl9ORE1B?oc=5
news.google.com/rss/articles/CBMiX0FVX3lxTFBpRzIyd1RwR3VoQ09MOFVhaVZDeHVtNVpnTUhpd18xMFJmTjRqVktxR2RiU3BMZmxERHJwS3NKSGltMURFeDFyQXlnc01ONW1GcGhNRXg5RlZKUl9ORE1B?oc=5
October 28, 2025 at 1:09 AM
Everybody can reply
MSI-H大腸がん、ニボルマブへのイピリムマブ追加でPFS延長傾向（CheckMate 8HW）／ESMO2025｜CareNet.com - CareNet.com
news.google.com/rss/articles/CBMiX0FVX3lxTFBpRzIyd1RwR3VoQ09MOFVhaVZDeHVtNVpnTUhpd18xMFJmTjRqVktxR2RiU3BMZmxERHJwS3NKSGltMURFeDFyQXlnc01ONW1GcGhNRXg5RlZKUl9ORE1B?oc=5
news.google.com/rss/articles/CBMiX0FVX3lxTFBpRzIyd1RwR3VoQ09MOFVhaVZDeHVtNVpnTUhpd18xMFJmTjRqVktxR2RiU3BMZmxERHJwS3NKSGltMURFeDFyQXlnc01ONW1GcGhNRXg5RlZKUl9ORE1B?oc=5
October 28, 2025 at 12:09 AM
Everybody can reply
MSI-H大腸がん、ニボルマブへのイピリムマブ追加でPFS延長傾向（CheckMate 8HW）／ESMO2025｜CareNet.com - CareNet.com
news.google.com/rss/articles/CBMiX0FVX3lxTFBpRzIyd1RwR3VoQ09MOFVhaVZDeHVtNVpnTUhpd18xMFJmTjRqVktxR2RiU3BMZmxERHJwS3NKSGltMURFeDFyQXlnc01ONW1GcGhNRXg5RlZKUl9ORE1B?oc=5
news.google.com/rss/articles/CBMiX0FVX3lxTFBpRzIyd1RwR3VoQ09MOFVhaVZDeHVtNVpnTUhpd18xMFJmTjRqVktxR2RiU3BMZmxERHJwS3NKSGltMURFeDFyQXlnc01ONW1GcGhNRXg5RlZKUl9ORE1B?oc=5
October 27, 2025 at 11:09 PM
Everybody can reply
MSI-H大腸がん、ニボルマブへのイピリムマブ追加でPFS延長傾向（CheckMate 8HW）／ESMO2025｜CareNet.com - CareNet.com
news.google.com/rss/articles/CBMiX0FVX3lxTFBpRzIyd1RwR3VoQ09MOFVhaVZDeHVtNVpnTUhpd18xMFJmTjRqVktxR2RiU3BMZmxERHJwS3NKSGltMURFeDFyQXlnc01ONW1GcGhNRXg5RlZKUl9ORE1B?oc=5
news.google.com/rss/articles/CBMiX0FVX3lxTFBpRzIyd1RwR3VoQ09MOFVhaVZDeHVtNVpnTUhpd18xMFJmTjRqVktxR2RiU3BMZmxERHJwS3NKSGltMURFeDFyQXlnc01ONW1GcGhNRXg5RlZKUl9ORE1B?oc=5
October 27, 2025 at 10:09 PM
Everybody can reply
MSI-H大腸がん、ニボルマブへのイピリムマブ追加でPFS延長傾向（CheckMate 8HW）／ESMO2025｜CareNet.com - CareNet.com
news.google.com/rss/articles/CBMiX0FVX3lxTFBpRzIyd1RwR3VoQ09MOFVhaVZDeHVtNVpnTUhpd18xMFJmTjRqVktxR2RiU3BMZmxERHJwS3NKSGltMURFeDFyQXlnc01ONW1GcGhNRXg5RlZKUl9ORE1B?oc=5
news.google.com/rss/articles/CBMiX0FVX3lxTFBpRzIyd1RwR3VoQ09MOFVhaVZDeHVtNVpnTUhpd18xMFJmTjRqVktxR2RiU3BMZmxERHJwS3NKSGltMURFeDFyQXlnc01ONW1GcGhNRXg5RlZKUl9ORE1B?oc=5
October 27, 2025 at 9:09 PM
Everybody can reply
monarchE試験のOS結果が発表／ESMO2025｜CareNet.com - CareNet.com
news.google.com/rss/articles/CBMiX0FVX3lxTFBnWGtNbkEzRWdBVzRDUFRKcjZBRDlFeVlkZUpEYjZIcExYZkUyc3pXMmVqSUt4eWczeDRTLUw5Q21JQ3JiLWpfT3cwdlVOVlZoT25NYklMTm5wMXBFLVhN?oc=5
news.google.com/rss/articles/CBMiX0FVX3lxTFBnWGtNbkEzRWdBVzRDUFRKcjZBRDlFeVlkZUpEYjZIcExYZkUyc3pXMmVqSUt4eWczeDRTLUw5Q21JQ3JiLWpfT3cwdlVOVlZoT25NYklMTm5wMXBFLVhN?oc=5
October 27, 2025 at 8:09 PM
Everybody can reply
monarchE試験のOS結果が発表／ESMO2025｜CareNet.com - CareNet.com
news.google.com/rss/articles/CBMiX0FVX3lxTFBnWGtNbkEzRWdBVzRDUFRKcjZBRDlFeVlkZUpEYjZIcExYZkUyc3pXMmVqSUt4eWczeDRTLUw5Q21JQ3JiLWpfT3cwdlVOVlZoT25NYklMTm5wMXBFLVhN?oc=5
news.google.com/rss/articles/CBMiX0FVX3lxTFBnWGtNbkEzRWdBVzRDUFRKcjZBRDlFeVlkZUpEYjZIcExYZkUyc3pXMmVqSUt4eWczeDRTLUw5Q21JQ3JiLWpfT3cwdlVOVlZoT25NYklMTm5wMXBFLVhN?oc=5
October 27, 2025 at 7:09 PM
Everybody can reply
monarchE試験のOS結果が発表／ESMO2025｜CareNet.com - CareNet.com
news.google.com/rss/articles/CBMiX0FVX3lxTFBnWGtNbkEzRWdBVzRDUFRKcjZBRDlFeVlkZUpEYjZIcExYZkUyc3pXMmVqSUt4eWczeDRTLUw5Q21JQ3JiLWpfT3cwdlVOVlZoT25NYklMTm5wMXBFLVhN?oc=5
news.google.com/rss/articles/CBMiX0FVX3lxTFBnWGtNbkEzRWdBVzRDUFRKcjZBRDlFeVlkZUpEYjZIcExYZkUyc3pXMmVqSUt4eWczeDRTLUw5Q21JQ3JiLWpfT3cwdlVOVlZoT25NYklMTm5wMXBFLVhN?oc=5
October 27, 2025 at 6:09 PM
Everybody can reply
monarchE試験のOS結果が発表／ESMO2025｜CareNet.com - CareNet.com
news.google.com/rss/articles/CBMiX0FVX3lxTFBnWGtNbkEzRWdBVzRDUFRKcjZBRDlFeVlkZUpEYjZIcExYZkUyc3pXMmVqSUt4eWczeDRTLUw5Q21JQ3JiLWpfT3cwdlVOVlZoT25NYklMTm5wMXBFLVhN?oc=5
news.google.com/rss/articles/CBMiX0FVX3lxTFBnWGtNbkEzRWdBVzRDUFRKcjZBRDlFeVlkZUpEYjZIcExYZkUyc3pXMmVqSUt4eWczeDRTLUw5Q21JQ3JiLWpfT3cwdlVOVlZoT25NYklMTm5wMXBFLVhN?oc=5
October 27, 2025 at 5:09 PM
Everybody can reply
monarchE試験のOS結果が発表／ESMO2025｜CareNet.com - CareNet.com
news.google.com/rss/articles/CBMiX0FVX3lxTFBnWGtNbkEzRWdBVzRDUFRKcjZBRDlFeVlkZUpEYjZIcExYZkUyc3pXMmVqSUt4eWczeDRTLUw5Q21JQ3JiLWpfT3cwdlVOVlZoT25NYklMTm5wMXBFLVhN?oc=5
news.google.com/rss/articles/CBMiX0FVX3lxTFBnWGtNbkEzRWdBVzRDUFRKcjZBRDlFeVlkZUpEYjZIcExYZkUyc3pXMmVqSUt4eWczeDRTLUw5Q21JQ3JiLWpfT3cwdlVOVlZoT25NYklMTm5wMXBFLVhN?oc=5
October 27, 2025 at 4:09 PM
Everybody can reply
👨⚕️ El Dr. Pau Mascaró, R5 de #OncologíaMédica en @vallhebron.com – VHIO, presentó en @myESMO una comunicación oral y un póster, un logro excepcional durante la residencia.
🔗 Descubre su experiencia 👉 https://resisoncovh.com/pau-mascaro-esmo-2025/
#ESMO2025 #ResisOncoVH
🔗 Descubre su experiencia 👉 https://resisoncovh.com/pau-mascaro-esmo-2025/
#ESMO2025 #ResisOncoVH
October 27, 2025 at 4:03 PM
Everybody can reply
1 likes